600422 昆药集团
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-7.1186.59310.9699.3677.847
总资产报酬率 ROA (%)-3.1992.8705.2044.9774.182
投入资产回报率 ROIC (%)-5.1074.9668.8517.3885.863

边际利润分析
销售毛利率 (%)19.26838.52243.46046.61141.516
营业利润率 (%)-23.7886.82111.0409.3676.003
息税前利润/营业总收入 (%)-22.8307.86011.2909.3466.225
净利润/营业总收入 (%)-22.5016.3738.9427.6234.654

收益指标分析
经营活动净收益/利润总额(%)80.40850.60791.08497.45093.560
价值变动净收益/利润总额(%)1.60936.0942.3382.3323.490
营业外收支净额/利润总额(%)1.2195.2900.752-0.419-4.161

偿债能力分析
流动比率 (X)1.9482.0191.5582.1081.740
速动比率 (X)1.5111.6571.2781.6501.308
资产负债率 (%)41.37341.04246.50635.30645.478
带息债务/全部投入资本 (%)24.83222.99516.82112.64220.592
股东权益/带息债务 (%)285.120315.840465.404654.239360.966
股东权益/负债合计 (%)107.070110.97089.575151.176116.170
利息保障倍数 (X)-18.24011.94967.811512.31913.459

营运能力分析
应收账款周转天数 (天)350.967169.215119.724111.20093.511
存货周转天数 (天)199.097130.148125.502138.091132.455